Short answer: probably, a little, and not in the dramatic way some wellness accounts describe. The longer answer is more interesting, because the relationship runs in both directions. Estrogen shapes which bacteria thrive in your gut, and your gut bacteria decide how much estrogen gets recycled back into your bloodstream. When estrogen falls at menopause, both halves of that loop shift. This article walks through what has actually been measured, what is still guesswork, and why we named a supplement company after it.
The estrobolome, in plain words
Your liver packages used estrogen for disposal by attaching a sugar molecule to it. In that form it is inactive and heads out through the bile into the gut. Some gut bacteria make an enzyme called beta-glucuronidase that snips the sugar off again. Once unpackaged, the estrogen can be reabsorbed through the gut wall and go round a second time. The collection of bacterial genes that do this was named the estrobolome in 2011, and a 2017 review in Maturitas laid out the idea properly: the gut is not just a bystander in hormone balance, it is one of the organs that regulates it.
This is not a fringe theory. In a 2012 study of healthy adults, the diversity of the gut microbiome tracked with the ratio of estrogen metabolites in urine. In postmenopausal women specifically, a 2014 study found the same link between microbiome richness and how estrogen was being broken down. The mechanism is real. What is less settled is how much it matters day to day.
What changes after menopause: the biggest study
The largest look at this so far came in 2022 from the Hispanic Community Health Study in the United States. Researchers sequenced the gut bacteria of 295 premenopausal women, 1,027 postmenopausal women and nearly a thousand men of matching ages. Three things stood out.
- Postmenopausal women looked more like men. Premenopausal women had the most diverse microbiomes of any group. After menopause, diversity trended down towards the male pattern, which is what you would expect if estrogen was doing some of the shaping.
- Specific bacteria moved. Postmenopausal women had less Akkermansia muciniphila, a species associated with a healthy gut lining, and fewer of several other species, with more of a few others including Sutterella and some Bacteroides and Prevotella strains.
- The estrobolome itself was quieter. Postmenopausal women carried fewer bacterial beta-glucuronidase genes. With less estrogen arriving in the gut, the bacteria that recycle it seem to lose ground, which is an elegant piece of biology and also slightly unfortunate, because it means the recycling loop weakens just when you could use it.
The same study connected some of those bacterial shifts to waist circumference, HDL cholesterol and blood pressure, which fits the broader picture that cardiometabolic risk rises after menopause. Whether the bacteria drive that or merely reflect it, nobody can yet say.
And the study that disagrees
You should know about this one, because most articles on the subject leave it out. In 2026 a group pooled seven studies covering 463 premenopausal and 1,222 postmenopausal women and looked for consistent differences. They did not find any. Overall diversity was the same. The two big bacterial phyla, Bacteroidetes and Firmicutes, were the same. Individual studies reported specific shifts, but they did not agree with each other on which ones.
How do you square that with the 2022 findings? Partly it is a question of tools. Pooling studies that used different sequencing methods and different populations washes out subtle effects. Partly it is that menopause is not the only thing changing in a woman’s fifties: diet, weight, medication and activity all move the microbiome, and they move at the same time. The fair reading is that menopause nudges the gut microbiome rather than transforming it, and that the nudge is easy to see in one large well-designed cohort and hard to see across a messy collection of small ones.
What that means for symptoms
Here the honest answer is that we do not have trials linking a specific microbiome change to a specific menopause symptom. Bloating and slower digestion are common complaints in perimenopause and have plausible hormonal explanations, since estrogen and progesterone both influence gut motility. Weight gain around the middle has a microbiome component in the general population. But nobody has yet shown that fixing the bacteria fixes the flashes.
Where the microbiome clearly does matter is in how plant compounds are handled, and this is the part that affects what you take.
Why your gut bacteria decide whether plant estrogens work
Two examples, both directly relevant to menopause supplements.
Isoflavones and equol. Daidzein, one of the isoflavones in soy and red clover, is converted by certain gut bacteria into equol, a compound that binds estrogen receptors more strongly than daidzein itself. Only some people carry the right bacteria. In Western populations it is roughly a third of adults, in Japan and China closer to half or more, which is one of the leading explanations for why soy trials in Asia tend to look better than soy trials in Europe. If you are an equol producer, isoflavones probably do more for you. Red clover has one practical advantage here: two of its four isoflavones, biochanin A and formononetin, are converted in the body to genistein and daidzein, so it delivers the full set rather than relying on one route.
Lignans and enterolactone. Flaxseed is the richest food source of a lignan called secoisolariciresinol. On its own it does very little. Gut bacteria convert it, in a chain of steps, into enterodiol and then enterolactone, the forms that circulate in the blood and interact weakly with estrogen receptors. The bacterial species involved were identified in 2005 and they are not the same as the equol producers. Antibiotics knock enterolactone levels down for weeks, which is about as clear a demonstration as you can get that this is a microbial product.
This is why we called the company Le Microbiome. Not because we think gut bacteria cause menopause, but because whether a plant-based menopause supplement does anything at all depends partly on the bacteria of the person taking it. It seemed dishonest to sell isoflavones and lignans without saying so.
What is worth doing
No supplement, ours included, has been shown to restore a premenopausal microbiome, and you should treat any product that claims otherwise with suspicion. What the general microbiome research supports is unglamorous and cheap.
- Fiber variety over fiber quantity. The strongest predictor of a diverse microbiome in large population studies is the number of different plant foods eaten in a week, not the grams of fiber. Thirty different plants a week is the figure that came out of the American Gut Project, and it counts herbs, seeds, nuts and pulses, so it is easier than it sounds.
- Whole flaxseed and soy foods, if you like them. Ground flaxseed is a lignan source and a fiber source at once. Tofu, edamame and tempeh deliver isoflavones in the form the Asian cohort studies were built on. Neither is a treatment, but both feed the bacteria you would want to keep.
- Fermented foods. A 2021 Stanford trial found that ten weeks of daily fermented foods increased microbiome diversity and lowered inflammatory markers, where a high-fiber diet alone did not, at least over that period.
- Movement and sleep. Both shift the microbiome measurably and both get worse in perimenopause for reasons that have nothing to do with bacteria. Fixing them helps on every front.
- Be skeptical of stool tests. Consumer microbiome tests will tell you what species you carry. They cannot yet tell you what to do about it, because the science has not reached the point where a given profile maps to a given action. Save the money.
Where EQUILI fits
EQUILI is built around 40 mg of red clover isoflavones, the dose used in the three-year safety study, together with 75 mg of flaxseed lignans that your gut bacteria convert into enterolactone. It does not contain probiotics and it does not claim to change your microbiome. It is a plant-based formula whose two main ingredients happen to pass through the microbiome on their way to working, which is why we think the gut deserves a mention on the label rather than a marketing slogan. The full evidence for each ingredient, including the trials that found nothing, is in the ingredients glossary.
References
- Peters BA, et al. Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the Hispanic Community Health Study/Study of Latinos. mSystems. 2022. DOI 10.1128/msystems.00273-22.
- Saravinovska K, et al. The impact of estrogen status on the gut microbiome: a systematic review and meta-analysis. Front Endocrinol. 2026. DOI 10.3389/fendo.2026.1780806.
- Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas. 2017. PMID 28778332.
- Flores R, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012. PMID 23259758.
- Fuhrman BJ, et al. Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab. 2014. PMID 25211668.
- Setchell KD, Clerici C. Equol: history, chemistry, and formation. J Nutr. 2010. PMID 20519412.
- Clavel T, et al. Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol. 2005. PMID 16204524.
- McDonald D, et al. American Gut: an open platform for citizen science microbiome research. mSystems. 2018. PMID 29795809.
- Wastyk HC, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021. PMID 34256014.
This article is for general information and is not a substitute for medical advice. EQUILI is a food supplement and is not intended to diagnose, treat, cure or prevent any disease.